iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Acquired by GSA Capital Partners LLP

GSA Capital Partners LLP lifted its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 397.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,696 shares of the company’s stock after purchasing an additional 9,347 shares during the quarter. GSA Capital Partners LLP owned 0.12% of iShares U.S. Pharmaceuticals ETF worth $794,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in IHE. Global Retirement Partners LLC lifted its holdings in iShares U.S. Pharmaceuticals ETF by 454.1% in the 1st quarter. Global Retirement Partners LLC now owns 410 shares of the company’s stock valued at $28,000 after purchasing an additional 336 shares in the last quarter. National Bank of Canada FI lifted its holdings in iShares U.S. Pharmaceuticals ETF by 274.0% in the 4th quarter. National Bank of Canada FI now owns 187 shares of the company’s stock valued at $35,000 after purchasing an additional 137 shares in the last quarter. Concourse Financial Group Securities Inc. lifted its holdings in iShares U.S. Pharmaceuticals ETF by 331.0% in the 1st quarter. Concourse Financial Group Securities Inc. now owns 543 shares of the company’s stock valued at $37,000 after purchasing an additional 417 shares in the last quarter. Fifth Third Bancorp lifted its holdings in iShares U.S. Pharmaceuticals ETF by 2,444.0% in the 1st quarter. Fifth Third Bancorp now owns 1,272 shares of the company’s stock valued at $86,000 after purchasing an additional 1,222 shares in the last quarter. Finally, Y.D. More Investments Ltd lifted its holdings in iShares U.S. Pharmaceuticals ETF by 29.0% in the 4th quarter. Y.D. More Investments Ltd now owns 516 shares of the company’s stock valued at $96,000 after purchasing an additional 116 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of IHE stock opened at $68.29 on Friday. The stock’s fifty day moving average is $66.18 and its two-hundred day moving average is $65.70. The firm has a market capitalization of $689.73 million, a P/E ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $55.36 and a fifty-two week high of $69.56.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.